Literature DB >> 31493273

Antineoplastic activity of artemisinin in adrenocortical carcinoma.

Luigi Lorini1, Salvatore Grisanti1, Roberta Ambrosini2, Deborah Cosentini1, Marta Laganà1, Luigi Grazioli2, Guido A M Tiberio3, Sandra Sigala4, Alfredo Berruti5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31493273     DOI： 10.1007/s12020-019-02077-7

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  16 in total

Review 1.  Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy.

Authors:  Thomas Efferth; Egon Koch
Journal:  Curr Drug Targets       Date:  2011-01       Impact factor: 3.465

Review 2.  Management of adrenal cancer: a 2013 update.

Authors:  M Terzolo; F Daffara; A Ardito; B Zaggia; V Basile; L Ferrari; A Berruti
Journal:  J Endocrinol Invest       Date:  2014-03       Impact factor: 4.256

Review 3.  Cancer combination therapies with artemisinin-type drugs.

Authors:  Thomas Efferth
Journal:  Biochem Pharmacol       Date:  2017-03-31       Impact factor: 5.858

4.  Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors.

Authors:  Judith E K Henning; Timo Deutschbein; Barbara Altieri; Sonja Steinhauer; Stefan Kircher; Silviu Sbiera; Vanessa Wild; Wiebke Schlötelburg; Matthias Kroiss; Paola Perotti; Andreas Rosenwald; Alfredo Berruti; Martin Fassnacht; Cristina L Ronchi
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

5.  Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study.

Authors:  Paola Sperone; Anna Ferrero; Fulvia Daffara; Adriano Priola; Barbara Zaggia; Marco Volante; Daniele Santini; Bruno Vincenzi; Giuseppe Badalamenti; Chiara Intrivici; Sabrina Del Buono; Silvia De Francia; Emmanouil Kalomirakis; Riccardo Ratti; Alberto Angeli; Luigi Dogliotti; Mauro Papotti; Massimo Terzolo; Alfredo Berruti
Journal:  Endocr Relat Cancer       Date:  2010-04-21       Impact factor: 5.678

6.  Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update.

Authors:  Laura Ferrari; Mélanie Claps; Salvatore Grisanti; Alfredo Berruti
Journal:  Eur Urol Focus       Date:  2015-06-22

7.  Integrated genomic characterization of adrenocortical carcinoma.

Authors:  Guillaume Assié; Eric Letouzé; Martin Fassnacht; Anne Jouinot; Windy Luscap; Olivia Barreau; Hanin Omeiri; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Nabila Elarouci; Silviu Sbiera; Matthias Kroiss; Bruno Allolio; Jens Waldmann; Marcus Quinkler; Massimo Mannelli; Franco Mantero; Thomas Papathomas; Ronald De Krijger; Antoine Tabarin; Véronique Kerlan; Eric Baudin; Frédérique Tissier; Bertrand Dousset; Lionel Groussin; Laurence Amar; Eric Clauser; Xavier Bertagna; Bruno Ragazzon; Felix Beuschlein; Rossella Libé; Aurélien de Reyniès; Jérôme Bertherat
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

8.  DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma.

Authors:  Jia-Li Zhang; Zeng Wang; Wei Hu; Sang-Sang Chen; Xiao-E Lou; Hui-Jun Zhou
Journal:  Microvasc Res       Date:  2013-03-01       Impact factor: 3.514

Review 9.  Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?

Authors:  Zhe Li; Qin Li; Jun Wu; Manyuan Wang; Junxian Yu
Journal:  Molecules       Date:  2016-10-07       Impact factor: 4.411

Review 10.  Antitumor Research on Artemisinin and Its Bioactive Derivatives.

Authors:  Yunqin Zhang; Guowei Xu; Shuqun Zhang; Dong Wang; P Saravana Prabha; Zhili Zuo
Journal:  Nat Prod Bioprospect       Date:  2018-04-09
View more
  1 in total

1.  Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.